20
Arevipharma Gmbh Radebeul De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Mycophenolate mofetil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2012-064 - Rev 00
This Chemical Type CEP, issued on October 16, 2013, remains in force until March 07, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1700 associated with this CEP further emphasizes